Results
RECRUITMENT
During the study, tocilizumab was adopted as part of usual care at which point recruitment was discontinued. By that time, 77 out of an intended 195 patients had been randomized, 27 to usual care and 28 and 22 to anakinra and tocilizumab, respectively (